Athena Pharma Private Limited, a active private limited company, was established on 15 December 2009 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U85100MH2009PTC197868. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Vikrant Dhruvaraj Singh (Director), Dhruvaraj Indrapal Singh (Director). Past directors included Paramjitsingh Ratansingh Bhumrah, Dhruvaraj Indrapal Singh. It holds no open charges and ₹1.60 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Unit No 620, Prestige Industrial Estate, Bawdi Cross Lane, Off Marve Road, Malad, (West),, Mumbai, Maharashtra, 400064.
U85100MH2009PTC197868
197868
15 December 2009
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Athena Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vikrant Dhruvaraj Singh | Director | 15 Dec 2009 | Current |
| Dhruvaraj Indrapal Singh | Director | 18 May 2012 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 18 May 2012 | Past |
| Pramod Abcsdd | Additional Director | 27 Sep 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Athena Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 20.71% decrease. The company also saw a substantial improvement in profitability, with a 41.25% increase in profit. The company's net worth Soared by an impressive increase of 16.9%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Athena Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹1,600,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Oct 2021 | Others | ₹1.60 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Athena Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Athena Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Athena Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Athena Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Athena Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
A charge registered on 12 Oct 2021 via Charge ID 100496336 with Others was fully satisfied on 09 May 2023. was recorded as a recent event.
A charge with Others amounted to Rs. 1.60 M with Charge ID 100496336 was registered on 12 Oct 2021. was recorded as a recent event.
The activity Dhruvaraj Indrapal Singh was appointed as a Director was appointed as a Director on 18 May 2012 & has been associated with this company since 13 years 7 months . was completed.
The activity Vikrant Dhruvaraj Singh was appointed as a Director was appointed as a Director on 15 Dec 2009 & has been associated with this company since 16 years 5 days . was completed.
The CIN of Athena Pharma Private Limited is U85100MH2009PTC197868.
Athena Pharma Private Limited is headquartered at Unit No 620, Prestige Industrial Estate, Bawdi Cross Lane, Off Marve Road, Malad, (West),, Mumbai, Maharashtra, 400064.
Athena Pharma Private Limited was incorporated on 15 December 2009.
The current directors of Athena Pharma Private Limited are
The primary industry of Athena Pharma Private Limited is Trade.
Athena Pharma Private Limited is unlisted.
The authorized capital of Athena Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Athena Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX